Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/472708]Researchers: Prof David Kaye (Principal investigator)
Brief description Pulmonary arterial hypertension (PAH) is a life threatening condition with few treatment options. It is marked by shortness of breath and reduced energy as a result of an unexplained constriction of the blood vessels in the lung. This results in reduced life expectancy. We are developing a new treatment that will relax the blood vessels in the lung to improve quality and length of life.
Funding Amount $AUD 137,684.70
Funding Scheme NHMRC Development Grants
Notes Development Grant
- nhmrc : 472708
- PURL : https://purl.org/au-research/grants/nhmrc/472708
